Although harboring a gain-of-function mutation in STING, fibroblasts from SAVI patients do not spontaneously release type I IFN or upregulate ISGs but are highly responsive to STING ligands19. Here, STING1 is linked to STING-associated vasculopathy with onset in infancy.